3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
115
Gliosarcoma
53
Brain Neoplasms
53
Glioma
47
Central Nervous System Neoplasms
30
Astrocytoma
29
Melanoma
26
Oligodendroglioma
14
Neuroblastoma
10
Neoplasm Metastasis
9
Recurrence
7
Ependymoma
7
Sarcoma
6
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Skin Neoplasms
5
Sarcoma, Ewing
5
Lymphoma
5
Breast Neoplasms
5
Spinal Cord Neoplasms
4
Somatostatinoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Colorectal Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Gastrinoma
3
Carcinoma, Islet Cell
3
Uveal Melanoma
2
Rhabdomyosarcoma
2
Interventions
eltrombopag
7
romiplostim
6
Cytarabine
3
Carboplatin
3
Platelet Transfusion
2
Cyclophosphamide
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sodium thiosulfate
1
pegfilgrastim
1
oprelvekin
1
ofatumumab
1
lusutrombopag
1
fludarabine
1
etoposide phosphate
1
avatrombopag
1
angiotensin I (1-7)
1
Tranexamic Acid
1
Stem Cell Transplantation
1
Sirolimus
1
Saline Solution
1
Rituximab
1
Microarray Analysis
1
Lenalidomide
1
Interleukin-11
1
Ifosfamide
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Gemcitabine
1
Flow Cytometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thrombocytopenia
×
Temozolomide
×
Clear all
No trials found.